Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.44 USD
Change Today 0.00 / 0.00%
Volume 2.1M
CYTX On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 4:30 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

E. Carmack Holmes M.D.

Former Director, Cytori Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 52 board members in 1 different organizations across 2 different industries.

See Board Relationships
77$98,814

Background*

Dr. E. Carmack Holmes, MD served as the Surgeon-in-Chief of the University of California Los Angeles (UCLA) Medical Center since 1994 and holds the position of William P. Longmire, Jr. Professor and Chairman of Department of Surgery at UCLA School of Medicine. Dr. Holmes joined UCLA in 1973 and has held professorial positions in the Divisions of Cardiothoracic Surgery and Surgical Oncology for over 30 years. Dr. Holmes served as Vice Chairman of UCLA for five years prior ...

Read Full Background

Corporate Headquarters*

3020 Callan Road
San Diego, California 92121

United States

Phone: 858-458-0900
Fax: --

Board Members Memberships*

Director

Education*

Unknown/Other Education
Duke University
MD
University of North Carolina

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$36,750
Total Calculated Compensation$98,814
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYTX:US $0.44 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$599.8K
Robin C. Stracey Chief Executive Officer and Director
Cesca Therapeutics Inc.
--
Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
$789.5K
Martin P. Rosendale Chief Executive Officer and Director
Nuo Therapeutics, Inc.
$385.0K
Andrey Semechkin Ph.D.Co-Chairman and Chief Executive Officer
International Stem Cell Corporation
$246.1K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTORI THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.